Spot-Check Noninvasive Hemoglobin (SpHb) Repeatability and Reproducibility
NCT03128853 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2020-04-27
Summary
Single-arm study to investigate the repeatability and reproducibility of SpHb measurements from the Rad-67 and DCI Mini sensor.
Conditions
- Anemia
- Healthy
Interventions
- DEVICE
-
Rad-67 and DCI Mini Sensor
Sponsors & Collaborators
-
Masimo Corporation
lead INDUSTRY
Study Design
- Allocation
- NA
- Purpose
- OTHER
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 1 Month
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-10-31
- Primary Completion
- 2016-11-15
- Completion
- 2016-11-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Early Administration of Recombinant Erythropoietin (RHEPO) in Transfusion Savings in Trauma Patients
NCT03867071 ·Status: COMPLETED ·Phase: NA
-
Repeat Dose Safety and Efficacy Study for Compound to Treat Anemia
NCT01047397 ·Status: COMPLETED ·Phase: PHASE2
-
Desidustat in the Treatment of Anemia in CKD
NCT04012957 ·Status: COMPLETED ·Phase: PHASE3
-
Search for Predictive Markers of Efficacy of ESAs in Patients With Non-myeloid Malignancies or Myelodysplastic Syndrome
NCT01546337 ·Status: TERMINATED
-
Subcutaneous (SC) Darbepoetin Alfa in Subjects With Symptomatic Congestive Heart Failure (CHF) & Anemia
NCT00086086 ·Status: COMPLETED ·Phase: PHASE2
-
Anemia Studies in Chronic Kidney Disease (CKD): Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor (PHI) Daprodustat in Non-Dialysis Subjects Evaluating Hemoglobin (Hgb) and Quality of Life (ASCEND-NHQ)
NCT03409107 ·Status: COMPLETED ·Phase: PHASE3
-
Absorption and Elimination of Radiolabeled Daprodustat
NCT03239522 ·Status: COMPLETED ·Phase: PHASE1
-
Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women
NCT02038023 ·Status: COMPLETED ·Phase: PHASE2
-
Validation of a New Standardized Clinical Anemia Evaluation Score Using a Hb Visual Scale in Nephrological Patients
NCT00478582 ·Status: COMPLETED ·Phase: NA
-
A Study of YTS109 Cell in Subjects With Relapsed/Refractory Autoimmune Hemolytic Anemia
NCT07075484 ·Status: COMPLETED ·Phase: PHASE1
-
A Dose Finding Study of KRN321(Darbepoetin Alfa) for the Treatment of Anemia in Subjects With Solid Tumor
NCT00359840 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate Efficacy and Safety of BGE-117 in the Treatment of Anemia of Aging
NCT04815603 ·Status: WITHDRAWN ·Phase: PHASE2
-
Ferumoxytol Versus Oral Iron in the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease Patients
NCT00255437 ·Status: COMPLETED ·Phase: PHASE3
-
Darbepoetin Alfa Treatment of Anemia in Hemodialysis Subjects
NCT00119587 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Treatment of Anemia in Pregnancy
NCT03317210 ·Status: COMPLETED ·Phase: PHASE4
-
Repeat Dose Safety Study for Compound to Treat Anemia
NCT00840320 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia.
NCT00440063 ·Status: TERMINATED ·Phase: PHASE4
-
Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
NCT07010237 ·Status: RECRUITING ·Phase: PHASE2
-
Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia
NCT01716923 ·Status: COMPLETED ·Phase: PHASE3
-
BioRBC Survival in Adults With Prior Antibody Response to BioRBCs
NCT02077751 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate Safety and Efficacy of GSK1278863 in Non-Dialysis Dependent (NDD) Subjects With Anemia Associated With Chronic Kidney Diseases (CKD)
NCT01977573 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of HSK39297 in Anti-C5 Treated PNH Patients With Anemia
NCT07052838 ·Status: COMPLETED ·Phase: PHASE3
-
Study With Oral Ferric Maltol for the Treatment of Iron Deficiency Anemia in Subjects With Chronic Kidney Disease
NCT02968368 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Safety and Tolerability of HRS-5965 in Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT06238544 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of Repeat-Dose Subcutaneous Darbepoetin Alfa in Subjects With Congestive Heart Failure and Anemia, and a Single Dose in Healthy Age- and Sex-Matched Control Subjects
NCT00117247 ·Status: COMPLETED ·Phase: PHASE1/PHASE2